BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1847251)

  • 1. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation.
    Keenan RJ; Lega ME; Dummer JS; Paradis IL; Dauber JH; Rabinowich H; Yousem SA; Hardesty RL; Griffith BP; Duquesnoy RJ
    Transplantation; 1991 Feb; 51(2):433-8. PubMed ID: 1847251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of class I- and class II-directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients.
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz M
    Transplantation; 1992 Jan; 53(1):181-9. PubMed ID: 1310170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients.
    Cerrina J; Le Roy Ladurie F; Herve PH; Parquin F; Harari S; Chapelier A; Simoneau G; Vouhe P; Dartevelle PH
    Transpl Int; 1992; 5 Suppl 1():S242-5. PubMed ID: 14621790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
    Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
    Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart--lung allograft recipients.
    Tikkanen J; Lemström K; Halme M; Pakkala S; Taskinen E; Koskinen P
    Clin Transplant; 2001 Apr; 15(2):77-88. PubMed ID: 11264632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation of cytomegalovirus-primed lymphocytes in bronchoalveolar lavages from lung transplant patients.
    Zeevi A; Uknis ME; Spichty KJ; Tector M; Keenan RJ; Rinaldo C; Yousem S; Duncan S; Paradis I; Dauber J
    Transplantation; 1992 Oct; 54(4):635-9. PubMed ID: 1329281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should heart-lung transplant donors and recipients be matched according to cytomegalovirus serologic status?
    Novick RJ; Menkis AH; McKenzie FN; Reid KR; Ahmad D
    J Heart Transplant; 1990; 9(6):699-706. PubMed ID: 2177496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and morbidity of cytomegalovirus disease associated with a seronegative recipient receiving seropositive donor-specific transfusion and living-related donor transplantation. A multicenter evaluation.
    Weir MR; Henry ML; Blackmore M; Smith J; First MR; Irwin B; Shen S; Genemans G; Alexander JW; Corry RJ
    Transplantation; 1988 Jan; 45(1):111-6. PubMed ID: 2827352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of donor factors other than serologic status on transmission of cytomegalovirus to transplant recipients.
    Chou SW; Norman DJ
    Transplantation; 1988 Jul; 46(1):89-93. PubMed ID: 2839917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection?
    Reinsmoen NL; Bolman RM; Savik K; Butters K; Hertz MI
    Transplantation; 1993 May; 55(5):1040-4. PubMed ID: 7684535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of CMV infection by screening for CMV antibodies in renal allograft recipients and their blood and kidney donors.
    Metselaar HJ; Ploeg RJ; Van Loon AM; Weiland HT; Rothbarth PH; Paul LC; Brand A; Schaafsma R; Hendriks GF; Jeekel J
    Scand J Infect Dis; 1988; 20(2):135-9. PubMed ID: 2840730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchiolitis obliterans organizing pneumonia-like reactions: a nonspecific response or an atypical form of rejection or infection in lung allograft recipients?
    Siddiqui MT; Garrity ER; Husain AN
    Hum Pathol; 1996 Jul; 27(7):714-9. PubMed ID: 8698317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation.
    Schulman LL; Weinberg AD; McGregor CC; Suciu-Foca NM; Itescu S
    Am J Respir Crit Care Med; 2001 Feb; 163(2):437-42. PubMed ID: 11179119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus as a risk factor in living-related renal transplantation. A prospective study.
    Pollak R; Barber PL; Prusak BF; Mozes MF
    Ann Surg; 1987 Mar; 205(3):302-4. PubMed ID: 3030201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.
    Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus infection and graft rejection in renal transplantation.
    Dickenmann MJ; Cathomas G; Steiger J; Mihatsch MJ; Thiel G; Tamm M
    Transplantation; 2001 Mar; 71(6):764-7. PubMed ID: 11330539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus infection in living-donor and cadaveric lung transplantations.
    Ohata K; Chen-Yoshikawa TF; Takahashi K; Aoyama A; Motoyama H; Hijiya K; Hamaji M; Menju T; Sato T; Sonobe M; Takakura S; Date H
    Interact Cardiovasc Thorac Surg; 2017 Nov; 25(5):710-715. PubMed ID: 29049752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.